Manulife Financial Corporation vs NeoGenomics Inc. Common Stock — how do they compare? Manulife Financial Corporation trades at $42.93 (market cap $71.31B), while NeoGenomics Inc. Common Stock trades at $16.85 (market cap $2.14B). The key difference: Manulife Financial Corporation is far larger — about 33.3× NeoGenomics Inc. Common Stock's market cap, and Manulife Financial Corporation pays a 3.15% dividend while NeoGenomics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Manulife Financial Corporation for 120 Days and NeoGenomics Inc. Common Stock for 0 Days on average.
| MFC | NEO | |
|---|---|---|
Market Cap | $71.31B | $2.14B |
Volume | 1,535,090 | 2,228,400 |
Sector | Financials | Health |
52-Week High | $44.77 | $19.91 |
52-Week Low | $31.64 | $7.19 |
Typical Hold Time | 120 Days | 0 Days |
Enterprise Value | $66.58B | $2.44B |
Dividend Yield | 3.15% | — |
Signals from Pluang's Aura AI — not financial advice
MFC trades at $43.10, up 0.56% today, with a neutral technical signal and bullish moving averages. Revenue grew to $53.01B in 2025, with a net income margin of 11.7% and a P/E of 16.73. Recent news includes a new Chief Marketing Officer appointment and strong institutional investments, such as Bank of America's $145.18 million stake.
The outlook is positive with analyst consensus at Buy (57.14%) and a price target of $34.24, though below the current price. Risks include competitive pressures and debt levels, but earnings beats and dividend payments support stability. Growth is driven by Asia expansion and reinsurance deals, yet valuation premiums may limit near-term upside.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Manulife provides life insurance and wealth management products and services to individuals and group customers in Canada, the United States, and Asia. Manulife is one of Canada's Big Three Life Insurance companies (the other two are Sun Life and Great West Life). As of Dec. 31, 2021, Manulife reported assets under management or administration of about CAD $1.4 trillion.
Read more on MFC →NeoGenomics, Inc. is a US cancer diagnostics company that provides genomic and pathology testing services, offering an oncology-focused testing menu used by oncologists, pathologists, and hospital systems across the cancer care continuum.
Read more on NEO →